ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

H. HENDERSON MD

5565 GROSSMONT CENTER DR BUILDING III, SUITE 510

La mesa | California | 91942

(619) 464-6051

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1749

$1.07M Total Retail Price of All Prescriptions

Rank: 43 out of 1749

454 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

9% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

8% of this provider’s 1,338 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$140 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CYMBALTA 431 156 1 12
RISPERIDONE 384 67 2 1
TRAZODONE HCL 380 106 3 2
ABILIFY 332 80 4 5
FLUOXETINE HCL 332 40 4 8
ZOLPIDEM TARTRATE 259 63 6 9
QUETIAPINE FUMARATE 246 0 7 4
TOPIRAMATE 221 22 8 29
SERTRALINE HCL 189 51 9 7
SEROQUEL 186 0 10 24
BENZTROPINE MESYLATE 182 0 R 11 3
MIRTAZAPINE 177 57 12 16
HYDROCODONE-ACETAMINOPHEN 157 23 S3 13 59
ESCITALOPRAM OXALATE 153 32 14 23
LAMOTRIGINE 146 0 15 14
CITALOPRAM HBR 136 48 16 10
PAROXETINE HCL 131 19 17 19
BUSPIRONE HCL 127 40 18 26
AMPHETAMINE SALT COMBO 121 0 S2 19 53
CLOZAPINE 119 0 20 11
SEROQUEL XR 108 12 21 25
FLUVOXAMINE MALEATE 106 0 22 54
FLUPHENAZINE HCL 103 0 23 36
LITHIUM CARBONATE 102 0 24 20
OLANZAPINE 102 0 24 6
DIVALPROEX SODIUM ER 96 20 26 13
BUPROPION HCL SR 95 0 27 22
CARISOPRODOL 91 0 R 28 138
TRIHEXYPHENIDYL HCL 76 45 R 29 33
SAPHRIS 74 0 30 56
ZIPRASIDONE HCL 74 0 30 28
LEXAPRO 72 14 32 38
AMITRIPTYLINE HCL 70 44 R 33 47
FANAPT 67 26 34 62
PERPHENAZINE 63 24 35 44
PRISTIQ ER 62 12 36 49
VENLAFAXINE HCL ER 60 0 37 17
CARBAMAZEPINE 58 0 38 46
ACETAMINOPHEN-CODEINE 56 20 S3 39 127
HYDROXYZINE PAMOATE 56 0 R 39 43
DIVALPROEX SODIUM 55 0 41 15
BUPROPION XL 54 0 42 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.